Kamal Pohar, MD
Urology · Cincinnati, OHNPI 1952350985
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,816 of the $19,591 with a category attached, or 75.6%. 7 manufacturers reported payments, led by Merck at 53.0% of the total. Reporting peaked in 2023 at $6,542 and has fallen 65.4% since, to $2,262 in 2025.
Across 30 payments — averaging $653.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$10K
- Photocure Inc$7K
- KARL Storz Endoscopy-america$2K
- Uroviu Corporation$115
- Janssen Scientific Affairs, LLC$72
- Urogen Pharma, Inc.$42
- plus $22 from 1 others
Across 248 payments — averaging $13,585 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$2.6M
- Pfizer$287K
- F. Hoffmann-la Roche AG$163K
- Janssen Research & Development, LLC$96K
- E.r. Squibb & Sons, L.L.C.$72K
- Photocure Inc$61K
- plus $87K from 3 others
What the payments were for
- Consulting fees$14,81676%
- Speaking & faculty fees$2,50013%
- Travel & lodging$1,3567%
- Food & beverage$9195%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 12 | $10,375 |
| Photocure Inc | 11 | $6,871 |
| KARL Storz Endoscopy-america | 3 | $2,096 |
| Uroviu Corporation | 1 | $115 |
| Janssen Scientific Affairs, LLC | 1 | $72 |
| Urogen Pharma, Inc. | 1 | $42 |
| Covidien LP | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cysview$6,614
- N/A$1,572
- KEYTRUDA$1,206
- Uro-G Flexible Cystoscope$115
How this compares
$19,591 in reported general payments places this provider in the 85th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Cincinnati
- Abhinav SidanaCincinnati$174K
- Paurush BabbarCincinnati$140K
- Marc PliskinCincinnati$108K
- Stephen BennettCincinnati$38K
- Michael RousseauCincinnati$26K
- Ryan FlynnCincinnati$16K
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.